Pharma

Your Article Summary

See Latest Articles

Repligen Elects Glenn L. Cooper, M.D. to the Board of Directors
Repligen, 08/26/09

Repligen Corporation announced that Glenn L. Cooper, M.D. has been elected to its Board of Directors. Dr. Cooper has extensive leadership experience in the pharmaceutical and biotechnology industries with expertise in transforming development stage companies into commercial organizations. Dr. Cooper was formerly the Chairman and Chief Executive Officer of Indevus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on urology and endocrinology.

Today in Execs on the Move...keeping you current

Receive free subspecialty "5-minute updates" via email

Medtronic Hires Renowned Cardiologist as Vice President of Medical Affairs for Coronary and Peripheral Business
Medtronic, 12/09/09

Robert J. Bertolini Elected to Genzyme's Board of Directors
Genzyme, 12/09/09

The Joint Commission Names Charles R. Buck to Board of Commissioners, Connie S. March to Represent Long Term Care Field
Joint Commission news, 12/07/09

 See all of Execs on the Move